Updated Jul 16, 2026
Hopfield Jessica has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.66M.
Jessica Hopfield is a corporate director at Insulet Corporation, a company known for its innovative Omnipod insulin delivery system. She has been involved in the company through her role as a director, contributing to its strategic direction.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | PODD | INSULET CORP | A — Grant or award | 1.7K | $0.00 | |
| 2025-05-22 | PODD | INSULET CORP | A — Grant or award | 778 | $0.00 | |
| 2025-05-13 | PODD | INSULET CORP | S — Open-market sale | 5.2K | $317.54 | $1.66M |
| 2025-05-13 | PODD | INSULET CORP | M — Option exercise | 5.2K | $28.87 | $151K |
Jessica Hopfield is a corporate director at Insulet Corporation, a company known for its innovative Omnipod insulin delivery system. She has been involved in the company through her role as a director, contributing to its strategic direction.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1.66M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hopfield Jessica profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.